Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
7 studies found for:    "Prurigo nodularis"
Show Display Options
Rank Status Study
1 Completed A Randomized Placebo-Controlled Study of the Neurokinin-1 (NK1) Receptor Antagonist Serlopitant Prurigo Nodularis (PN)
Condition: Prurigo Nodularis
Interventions: Drug: serlopitant;   Drug: Placebo
2 Completed
Has Results
Safety and Efficacy of CC-10004 for Prurigo Nodularis
Condition: Prurigo Nodularis
Intervention: Drug: CC-10004
3 Unknown  Effectiveness of the Selective Serotonin Reuptake Inhibitor,Citalopram (Cipralex), in Prurigo Nodularis
Condition: Prurigo Nodularis
Intervention: Drug: citalopram (cipralex)
4 Active, not recruiting Open Label Extension Study of Nalbuphine HCl ER in Patients With Prurigo Nodularis
Conditions: Prurigo Nodularis;   Nodularis Prurigo;   Prurigo
Interventions: Drug: nalbuphine HCl ER 90 mg BID;   Drug: nalbuphine HCl ER 120 mg BID;   Drug: nalbuphine HCl ER 180 mg BID
5 Completed Evaluation of the Antipruritic Effect of Elidel (Pimecrolimus) in Non-atopic Pruritic Disease
Condition: Prurigo Nodularis
Interventions: Drug: Pimecrolimus;   Drug: Hydrocortisone
6 Completed Study of Nalbuphine HCl ER Tablets in Patients With Prurigo Nodularis
Conditions: Prurigo Nodularis;   Nodularis Prurigo;   Prurigo;   Pruritus
Interventions: Drug: nalbuphine HCl ER tablets 90 mg BID;   Drug: nalbuphine HCl ER tablets 180 mg BID;   Drug: Placebo tablets BID
7 Not yet recruiting Dapsone Prurigo Study
Condition: Lichen Simples Chronicus and Prurigo
Intervention: Drug: Dapsone gel - verum

Study has passed its completion date and status has not been verified in more than two years.